Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial.
Hosokawa K, Abe K, Kishimoto J, Kobayakawa Y, Todaka K, Tamura Y, Tatsumi K, Inami T, Ikeda N, Taniguchi Y, Minatsuki S, Murohara T, Yasuda S, Fukuda K, Tsutsui H. Hosokawa K, et al. Among authors: todaka k. BMJ Open. 2022 Jul 19;12(7):e061225. doi: 10.1136/bmjopen-2022-061225. BMJ Open. 2022. PMID: 37070473 Free PMC article.
Safety, Tolerability, and Pharmacokinetics of NK-104-NP.
Nakano K, Matoba T, Koga JI, Kashihara Y, Fukae M, Ieiri I, Shiramoto M, Irie S, Kishimoto J, Todaka K, Egashira K. Nakano K, et al. Among authors: todaka k. Int Heart J. 2018 Sep 26;59(5):1015-1025. doi: 10.1536/ihj.17-555. Epub 2018 Aug 29. Int Heart J. 2018. PMID: 30158384 Free article. Clinical Trial.
Safety and efficacy of brilliant blue g250 (BBG) for lens capsular staining: a phase III physician-initiated multicenter clinical trial.
Hisatomi T, Enaida H, Yoshida S, Hirakata A, Ohji M, Nishida K, Kubota T, Ogata N, Matsui T, Kimura K, Sonoda KH, Uchiyama M, Kishimoto J, Todaka K, Nakanishi Y, Ishibashi T. Hisatomi T, et al. Among authors: todaka k. Jpn J Ophthalmol. 2020 Sep;64(5):455-461. doi: 10.1007/s10384-020-00763-y. Epub 2020 Aug 18. Jpn J Ophthalmol. 2020. PMID: 32809075
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol Secretion.
Oda S, Ashida K, Uchiyama M, Sakamoto S, Hasuzawa N, Nagayama A, Wang L, Nagata H, Sakamoto R, Kishimoto J, Todaka K, Ogawa Y, Nakanishi Y, Nomura M. Oda S, et al. Among authors: todaka k. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3865-e3880. doi: 10.1210/clinem/dgab450. J Clin Endocrinol Metab. 2021. PMID: 34143883 Clinical Trial.
Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity.
Arima M, Inoue H, Nakao S, Misumi A, Suzuki M, Matsushita I, Araki S, Yamashiro C, Takahashi K, Ochiai M, Yoshida N, Hirose M, Kishimoto J, Todaka K, Hasegawa S, Kimura K, Kusuhara K, Kondo H, Ohga S, Sonoda KH. Arima M, et al. Among authors: todaka k. BMJ Open. 2021 Jul 27;11(7):e047003. doi: 10.1136/bmjopen-2020-047003. BMJ Open. 2021. PMID: 34315793 Free PMC article.
Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study.
Kimura K, Kanto T, Shimoda S, Harada K, Kimura M, Nishikawa K, Imamura J, Ogawa E, Saio M, Ikura Y, Okusaka T, Inoue K, Ishikawa T, Ieiri I, Kishimoto J, Todaka K, Kamisawa T. Kimura K, et al. Among authors: todaka k. EBioMedicine. 2022 Jun;80:104069. doi: 10.1016/j.ebiom.2022.104069. Epub 2022 May 20. EBioMedicine. 2022. PMID: 35605429 Free PMC article. Clinical Trial.
A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis.
Kobayakawa Y, Todaka K, Hashimoto Y, Ko S, Shiraishi W, Kishimoto J, Kira JI, Yamasaki R, Isobe N; Pooled Resource Open-Access ALS Clinical Trials Consortium. Kobayakawa Y, et al. Among authors: todaka k. J Neurol Sci. 2022 Nov 15;442:120389. doi: 10.1016/j.jns.2022.120389. Epub 2022 Aug 24. J Neurol Sci. 2022. PMID: 36041329 Free article.
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
Nakano Y, Yamamoto M, Matoba T, Katsuki S, Nakashiro S, Takase S, Akiyama Y, Nagata T, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H. Nakano Y, et al. Among authors: todaka k. J Atheroscler Thromb. 2023 Aug 1;30(8):907-918. doi: 10.5551/jat.63507. Epub 2022 Dec 1. J Atheroscler Thromb. 2023. PMID: 36450458 Free PMC article. Clinical Trial.
74 results